Frank R. Arko III, MD
Chief, Vascular and Endovascular Surgery
Professor, Cardiovascular Surgery
Co-Director, Aortic Institute
Sanger Heart and Vascular Institute
Atrium Health
Charlotte, North Carolina
Disclosures: Consultant to Penumbra, Inc.

The Indigo® System Lightning™ 12 (Penumbra, Inc.) is an intelligent aspiration system powered by the Penumbra ENGINE™ (Figure 1). Indigo, now with Lightning, utilizes a unique mechanism of action to help optimize thrombus removal procedures by differentiating between thrombus and blood. Lightning enables clot detection so the physician knows when the catheter is in thrombus and when it is in patent flow. Lightning has also demonstrated an 18:1 potential fluid loss savings during bench top testing when used versus the Dynamic Aspiration Tubing.

Figure 1. Lightning Intelligent Aspiration.

Lightning™ Intelligent Aspiration comes packaged with the Indigo CAT™ 8 or the newest CAT12, the next generation of the Indigo System catheters. CAT12 features a large 0.131-inch lumen and angled tip for additional circumferential sweep (Figure 2). Made of laser-cut hypotube technology, the CAT12 is Penumbra’s most trackable and torqueable catheter to date. This combination of intelligent aspiration and large-lumen catheter engineering forms Lightning™ 12: the latest generation in clot removal technology.

Figure 2. Indigo System Catheter CAT12.


Patrick E. Muck, MD, RVT, FACS
Chief of Vascular Surgery
Program Director, Vascular Fellowship & Integrated Residency
Good Samaritan Hospital
Cincinnati, Ohio
Disclosures: Owns public stock in Penumbra; consultant and course director for Penumbra, Inc.


A 77-year-old woman presented to the emergency department with a history of esophageal varices and bleeding, contraindicating her for tissue plasminogen activator (tPA). Scans revealed a left lower extremity venous thrombus extending from the calf to the common iliac vein (CIV) (Figure 1).

Figure 1. Scan showing preoperative left venous thrombus.


  • Access was gained using an 8-F sheath in the left popliteal vein, which was then upsized to a 12-F sheath.
  • Lightning was hooked up to the Indigo System Catheter CAT12 and placed into the access sheath.
  • Using the HTORQ angle on CAT12 to torque the catheter, several passes were made through the affected area, from the left popliteal to the external iliac vein (EIV) and internal iliac vein.
  • The SEP12 was introduced to help clear the lumen of the catheter due to the heavy thrombus burden. Total aspiration time was 34 minutes.
  • Intravascular ultrasound (IVUS) revealed May-Thurner syndrome, which was treated with stenting in the CIV and EIV; 100% of the clot was resolved (Figure 2).
  • Figure 3 shows the total thrombus removed.

Figure 2. Postoperative angiogram showing 100% resolution of thrombus.

Figure 3. Image showing the total thrombus removed.


The Lightning 12 addition to the Indigo Aspiration System is a formative development in the thrombectomy space. Lightning Intelligent Aspiration allows physicians to optimize the thrombus removal needed to complete venous thrombus procedures that would otherwise be more complicated. The clot detection algorithm paired with the audiovisual cues lets the physician know when the catheter is in thrombus versus when it is in blood. The latest addition to the catheter line, the CAT12, is Penumbra’s most torqueable and trackable catheter to date. The new HTORQ angle is complemented by the large lumen when accessing wall-adherent thrombus in the venous space.


Ripal T. Gandhi, MD, FSIR, FSVM
Miami Cardiac and Vascular Institute
Miami Cancer Institute
Miami Vascular Specialists
Professor, FIU Herbert Wertheim College
of Medicine
Associate Clinical Professor, University of South Florida College of Medicine
Miami, Florida
Disclosures: None.


A 67-year-old woman with a history of venous thrombus and iliac venous stenting presented with significant recurrent left lower extremity venous thrombus, and the patient’s symptoms did not significantly improve with anticoagulation alone. Of note, the patient was not a good candidate for thrombolysis due to retroperitoneal hemorrhage from lymph node biopsy several days earlier. The decision was made to proceed with mechanical thrombectomy. A venogram was performed via left popliteal vein access, which demonstrated thrombosis of the left femoral vein (FV) and common femoral vein (CFV) (Figure 1) and the previously stented left common iliac vein (CIV) and external iliac vein (EIV) (Figure 2).

Figure 1. Venogram showing thrombosis of the left FV and CFV.

Figure 2. Venogram showing stents in the left CIV and EIV.


  • The newly available Indigo CAT12 Aspiration Catheter (Penumbra, Inc.) was utilized to perform mechanical thrombectomy of the FV, CFV, and EIV and CIV without the use of thrombolytics (Figure 3).
  • A postthrombectomy venogram (Figure 4 and Figure 5) showed complete resolution of thrombus in all the deep veins of the left lower extremity.
  • Significant thrombus was aspirated from the Indigo CAT12 Aspiration Catheter (Figure 6), with minimal blood loss given the utilization of the specially designed Lightning Intelligent Aspiration.
  • May-Thurner narrowing of the left CIV was noted and treated with a Vici stent (Boston Scientific Corporation), with IVUS before treatment (Figure 7) showing thrombus in the iliac vein.
  • IVUS after thrombectomy and stenting showed a widely patent lumen (Figure 8). The patient had significant improvement in her symptoms after the procedure.

Figure 3. Venogram showing CAT12 in the CIV.

Figure 4. Postthrombectomy venogram.

Figure 5. Postthrombectomy venogram.

Figure 6. Image of thrombus aspirated using the Indigo CAT12 Aspiration Catheter.

Figure 7. IVUS image showing May-Thurner narrowing of the left CIV and thrombus in the iliac vein.

Figure 8. IVUS image showing a widely patent lumen after thrombectomy and stenting.


The Indigo CAT12 Aspiration Catheter is indicated for removal of fresh, soft emboli and thrombi from vessels of the peripheral venous systems. The Indigo CAT12 represents an advancement in mechanical thrombectomy given its ability to aspirate large-volume thrombus in a single-session setting, which is especially beneficial in larger-lumen vascular beds, such as large-caliber veins as demonstrated in this case. The catheter is robust and trackable, and the large lumen allows for thrombectomy either with a guidewire in place or without a guidewire. Aspiration may also be performed in conjunction with an Indigo System Separator™ (Penumbra, Inc.) to allow for constant clearing of thrombus from the lumen of the catheter. The 1:1 torqueability of the catheter was especially valuable for aspirating thrombus along the circumference of the larger-diameter iliac veins.

The new Indigo System is engineered to allow for thrombectomy while helping to prevent excessive blood loss during the procedure. When in free-flowing blood, this technology automatically stops aspirating blood and hence limits unnecessary loss of blood. An intuitive clicking sound is made by the device that signals that one is in free-flowing blood. When the catheter is engaged on thrombus or embolic material, the clicking sound ceases. This allows the operator to focus on the procedure and not on the canister.

In summary, Lightning 12 is an excellent addition to the peripheral thrombectomy armamentarium and may allow for successful treatment of complex patients.


Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM
Professor of Radiology and Surgery
Executive Vice Chairman
Department of Diagnostic, Molecular, and Interventional Radiology
Icahn School of Medicine at Mount Sinai
New York, New York
Disclosures: None.

The acute pulmonary embolism (PE) treatment paradigm is evolving to treat patients that have emergent symptoms and are unable to tolerate long thromboaspiration procedures. Now, the goal with thrombus removal in PE is to safely and effectively remove thrombus and potentially reduce treatment time. Thrombolysis is not a universal option for all patient groups, especially if the patient has an absolute or relative contraindication to a fibrinolytic agent. Large-bore embolectomy, when paired with a syringe, has led to variable results, with questions regarding the ideal technique to achieve a uniform state of vacuum aspiration.1 The catheters used to aspirate should ideally be atraumatic and easily deliverable to be able to access and establish flow through the lobar branches of the pulmonary artery (PA), reducing right heart strain and PA pressure. Sustained aspiration from the Indigo System provides physicians with an alternative option for patients who are not ideal candidates for lytics or open embolectomy and provides a frontline therapy option that still preserves the use of any adjunctive therapy.

The Indigo Aspiration System provides a treatment option that is now cleared by the FDA to treat PE. The sustained aspiration from the Penumbra ENGINE provides constant uninterrupted full-vacuum aspiration throughout the procedure, addressing the constraints of syringe-based large-bore embolectomy, which include vacuum dropoff from the syringe filling with fluid. The CAT8’s large lumen can allow for efficient clot removal, which can be enhanced when paired with mechanical separation from the SEP8. Engineered to be trackable, deliverable, and torqueable, the CAT8’s atraumatic tip can navigate the lobar anatomy of the PA to help establish inflow and outflow, helping to restore patient vitals to normal.

The EXTRACT-PE study completed in 2019 evaluated the safety and efficacy of the Indigo Aspiration System in the management of submassive PE. The Indigo System Catheter CAT8 was used across 22 sites in the United States in patients with submassive PE who did not receive thrombolytics (98.3%), with a right ventricular/left ventricular (RV/LV) ratio reduction of 27.3% at 48 hours. The on-table PA pressures were statistically reduced, and the median device time was 37 minutes. This procedure time has been embraced by countless interventionalists concerned about prolonged case times with other thromboaspiration technologies. The major adverse event rate in EXTRACT-PE was 1.7%, and patients had a median intensive care unit stay of < 1 day. The EXTRACT-PE trial demonstrated that the Indigo System can provide immediate mechanical relief using sustained aspiration. As PE treatment options continue to grow, the EXTRACT-PE results with the Indigo System serve as a promising data set in helping move the PE landscape forward.

This new thromboaspiration technology allows for clot removal and potential reduction in right heart and PA pressure. It is low-profile and deliverable to all vascular territories in the pulmonary circulation. It is a welcome addition to our existing endovascular technologies for the treatment of acute PE.

1. Giri J, Sista A, Weinberg I, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation. 2019;140:e774-e801. doi: 10.1161/CIR.0000000000000707


Michael S. Rosenberg, MD, FSIR, FACR
Associate Professor of Radiology and Surgery
Executive Medical Director of Interventional Radiology & Vascular Imaging
MHealth Fairview System Medical Director for Interventional Radiology Operations
University of Minnesota
Minneapolis, Minnesota
Disclosures: None.


A 48-year-old man presented with a 3-day history of acute shortness of breath and chest pressure. The patient had a history of lower left extremity venous thrombus dating back to 2013, with chronic residual nonocclusive popliteal vein thrombus in 2018. The patient also had a history of bilateral PE dating back to October 2017, at which point rivaroxaban was prescribed. After considering the acute onset of symptoms and the history of thrombosis, we decided to proceed with the Indigo System to treat the bilateral PE in one session.


  • CT revealed that the patient had a bilateral PE with an elevated RV/LV ratio of 2.26, an elevated troponin level of 0.151 μg/mL, and PA pressures at 35 mm Hg.
  • We gained access through the right CFV using a 14-F sheath. To gain access into the lobar branches, a 5-F, 125-cm vertebral catheter over a 0.035-inch stiff, angled Glidewire® (Terumo Interventional Systems) was used. The Indigo CAT8 XTORQ was advanced over the select catheter and used in both the right and left PAs.
  • Immediately postprocedure, a decrease in PA pressure from 35 to 27 mm Hg was observed. In addition, the RV/LV ratio decreased from 2.26 to 1.09, over a > 50% on-table decrease.
  • At the 30-day follow-up, the patient no longer had residual shortness of breath or exertional dyspnea. The patient’s echocardiogram showed normal RV size and function. Figure 1 and Figure 2 show pre- and postprocedural angiograms, respectively, of the patient’s left pulmonary anatomy.

Figure 1. Preprocedural CT of the patient’s left pulmonary anatomy.

Figure 2. Postprocedural CT of the patient’s left pulmonary anatomy.


Single-session management of PE using the Indigo System CAT8 allows physicians to treat emergent patients. In the current treatment of PE, standard treatments such as anticoagulation, thrombolysis, and open embolectomy have limitations. Continuous, sustained aspiration can effectively remove thrombus and potentially reduce the use of thrombolytics. The Indigo Aspiration System, along with the Penumbra ENGINE and Indigo CAT8, provide a frontline treatment option for PE patients that can lower on-table PA pressures and reduce RV/LV ratios by 27.3%, per their investigational device exemption trial, EXTRACT-PE.1 The trial and our case experience at the University of Minnesota with CAT8 show that sustained aspiration with the Indigo System can provide safe mechanical relief in the treatment of PE.

1. Sista A. Evaluating the safety and efficacy of the Indigo® aspiration system in acute pulmonary embolism

(EXTRACT-PE). Presented at Vascular InterVentional Advances (VIVA) 2019; November 6, 2019; Las Vegas, Nevada.


Eric Moldestad, MD
Interventional Radiology
Desert Radiology
Director of Interventional Radiology
Henderson Hospital
Las Vegas, Nevada
Disclosures: None.


A 47-year-old woman with no previous history of thromboembolism presented with sudden-onset PE. CT showed a bilateral PE with right heart strain.


  • Access was gained through the groin using an 8-F Destination® sheath (Terumo Interventional Systems). Mean PA pressure at the start of the case was 35 mm Hg.
  • Low-dose tPA was dripped into the left and right lobes of the PA. Immediately after, Lightning with the Indigo System Catheter CAT8 was used to aspirate thrombus in the left PA (Figure 1 and Figure 2).
  • Due to increased amounts of thrombus in the right lobe, the SEP8 was introduced to clear the lumen of the catheter (Figure 3 and Figure 4). The CAT8 with SEP8 were cycled through using several passes until thrombus burden was significantly reduced. Figure 5 shows the right PA after Lightning™ 8 treatment.
  • Mean PA pressure postintervention was 21 mm Hg.

Figure 1. Left PA pre-Lightning 8.

Figure 2. Left PA post-Lightning 8.

Figure 3. Right PA preintervention.

Figure 4. Right PA with the SEP8.

Figure 5. Right PA postintervention.


In PE cases, patients are often emergent and need interventions that provide immediate relief. In this case, the PE patient had an extremely high PA pressure of 35 mm Hg, which we were able to significantly reduce by 40%. With Lightning 8, we were able to clear the loft lobar branch and detect that we had established substantial inflow and outflow so we could move to the next affected lobe. The audiovisual cues from Lightning and the thrombus detection algorithm enabled us to navigate the lobar branches of the PA. Lightning’s audio cues, in the form of clicking, help with clot detection to optimize thrombus removal and focus on the screen rather than monitor flow through the tubing and canister. From syringe aspiration to sustained aspiration and now to intelligent aspiration, the aspiration thrombectomy field has grown leaps and bounds, now finding itself at a place where the Indigo System with the Lightning Intelligent Aspiration optimizes the thrombus removal procedure by differentiating between thrombus and blood.


Gianmarco de Donato, MD
Associate Professor of Vascular Surgery
Department of Medicine, Surgery and Neuroscience
University of Siena
Siena, Italy
Disclosures: None.

With contributions from Edoardo Pasqui, MD; Carlo Setacci, MD; and Giancarlo Palasciano, MD

Surgical management of lower extremity acute limb ischemia (ALI) has been considered the preferred treatment for years. However, it has also been associated with an unsatisfying revascularization rate due to the detection of residual thrombus in distal vessels. Intraoperative angiography can identify any arterial imperfection after surgical thromboembolectomy, which may be corrected simultaneously by endovascular techniques. However, these “hybrid procedures” include the invasiveness of open surgery and carry the risk of incomplete thrombus removal or vessel damage.1

Consequently, many new endovascular devices have been proposed to increase treatment success, decrease complications, and rapidly improve perfusion. Percutaneous manual thromboaspiration was the first technique proposed, followed by a series of percutaneous mechanical thrombectomy devices based on a different mechanism of action (mechanical fragmentation, aspiration, rheolytic thrombectomy, and their combinations). Many of the first-generation mechanical endovascular devices for thrombus removal have failed to be adequately successful or have been associated with unacceptable complication rates. The reasons have been mainly related to the limited trackability, the risk of vessel injury, and/or the incidence of incomplete revascularization, and the risk of bleeding and hemolysis.2,3

The Indigo System has been designed to address the limitations of traditional treatment options. The Indigo System aspiration catheter is available in a range of lengths and diameters that, when connected to the proprietary Penumbra Aspiration Pump, may help atraumatically remove the thrombus under continuous aspiration. By capturing the clot without maceration and under high aspiration power, the risk for distal emboli may be minimized.

The catheters, which were initially designed for intracranial navigation for the treatment of acute stroke, are provided with an atraumatic tip. In particular, the Indigo catheters vary from 3 to 8 F—enabling the operator to remove thrombus from small vessels such as the pedal arch but also from large vessels such as the aorta or iliac arteries, due to the circumferential aspiration from the tip shapes offered in CAT8.

The Separator is specifically designed for mechanical clot engagement and is particularly helpful in acute-on-chronic thrombosis, in-stent/in-bypass fresh occlusion, and in below-the-knee (BTK) and all the way to the pedal arch thrombi localization (Figure 1).

Figure 1. Angiography showed the presence of a popliteal aneurysm with massive endoluminal thrombosis and distal multilevel embolism tibial (A) and plantar arteries (B).


The INDIAN registry is a prospective, multicenter registry designed to investigate, in a controlled setting, the safety and initial efficacy of the Indigo System in the treatment of acute peripheral arterial thromboembolism. Vessel patency is assessed using the thrombolysis in myocardial infarction (TIMI) score classifications, both before and after the use of the device.

The primary outcome is the rate of TIMI 2-3 revascularization after treatment using the Indigo System. A preliminary analysis of the first 143 patients showed a technical success (defined as complete or near-complete revascularization—TIMI 2-3 flow) after thromboaspiration procedure alone in 89.5%. After adjunctive endovascular (angioplasty, stenting, or lysis), TIMI 2-3 was reached in up to 95.3% of patients. At discharge, there have been no adverse device events, and clinical success at 1 month (defined as the absence of death and limb loss) is 98.6%.4

Localization of the thrombus was quite variable in our cohort of patients, although in the majority of cases (67%), patients presented with thrombus in the popliteal or BTK vessels. The thromboaspiration with the Indigo System was particularly useful in situations of multilevel vessel acute occlusion. Figure 1 shows a popliteal aneurysm with massive endoluminal thrombosis and distal multilevel embolism in the tibial and plantar arteries. In such a case, the use of multiple catheters (CAT8 for popliteal, CAT6 for tibials, and CAT3 for plantars) was particularly helpful (Figure 2 and Figure 3).

Figure 2. Advancement of the CAT8 and CAT6 through the popliteal and tibial arteries (A, B). CAT3 advanced through the pedal loop (C).

Figure 3. Angiography after Indigo power aspiration and popliteal aneurysm repair with a stent graft (Viabahn, Gore & Associates) revealed a patency of the tibial (A) and plantar (B) vessels.

Preliminary data from the INDIAN registry is promising regarding early safety and efficacy for the revascularization of acute peripheral arterial occlusions with thromboaspiration as primary therapy. Such results give more evidence for a shift of treatment recommendation toward endovascular options in the patients with ALI, as already suggested by the recent European Society of Cardiology/European Society for Vascular Surgery guidelines.

1. de Donato G, Setacci F, Sirignano P, Galzerano G, Massaroni R, Setacci C. The combination of surgical embolectomy and endovascular techniques may improve outcomes of patients with acute lower limb ischemia. J Vasc Surg. 2014;59:729-36.

2. Deák Z, Strube H, Sadeghi-Azandaryani M, et al. Rotational thrombectomy of acute peripheral vascular occlusions using the ThromCat XT device: techniques, indications, and initial results. Diagn Interv Radiol. 2011;17:283-289. doi: 10.4261/1305-3825.DIR.3687-10.2

3. Carrera LA, Reddy R, Pamoukian VN, et al. Massive intravascular hemolysis with mechanical rheolytic thrombectomy of a hemodialysis arteriovenous fistula. Semin Dial. 2013;26: E5-7. doi: 10.1111/j.1525-139X.2012.01104.x

4. As presented on November 21, 2019, at VEITH 2019 by Dr. Gianmarco de Donato, University of Siena, Italy.

5. Björck M, Earnshaw JJ, Acosta S, et al. Editor’s choice—European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischemia. Eur J Vasc Endovasc Surg. 2020;59:173-218. doi: 10.1016/j.ejvs.2019.09.006


Thomas S. Maldonado, MD
Schwartz-Buckley Professor of Surgery, Vascular Division
New York University Langone Medical Center
Director, Venous Thromboembolic Center and Aortic Center
NYU Langone Health
Chief of Vascular Surgery
Manhattan Veterans Administration Hospital
New York, New York
Disclosures: None.

STRIDE is the newest study from Penumbra evaluating the removal of thrombus with the Indigo Aspiration System in patients with lower extremity ALI. The goal of this study is to create a prospective multicenter study that provides safety and performance data on the Indigo System as a frontline percutaneous aspiration thrombectomy approach for ALI patients for whom immediate treatment and revascularization can maintain limb viability. STRIDE is currently ongoing.


A 57-year-old man presented with acute-onset left calf pain for the past 10 days and had recently taken a 4-hour flight. The patient, an active smoker, also had a history of pulmonary hypertension and hypercholesterolemia. Upon arrival to the hospital, physical examination and a Doppler ultrasound examination revealed absent pulses in the left foot. Although motor function was still intact, there was decreased sensation and delayed capillary refill in the left foot and calf. CT revealed an occlusion in the popliteal artery (Figure 1).

Figure 1. Preintervention.


  • A 0.014-inch wire was used to track to the occlusion, and the Indigo System CAT6 was used to aspirate the clot (Figure 1). The XTRACT technique was used to cork the clot at the tip of the catheter and remove the catheter along with the clot from the body (Figure 2 and Figure 3).
  • With a device time of only 5 minutes and no use of tPA, the patient’s symptoms were promptly relieved with no recurring episodes to date.

Figure 2. Postintervention.

Figure 3. Image of clot removed.


Traditionally, tPA or open embolectomy were the primary treatment options for acute-to-chronic lesions. More recently, a number of other endovascular mechanical thrombectomy devices have been introduced as treatment options; however, many physicians still rely on adjunctive tPA, either to “lace” the thrombus at time of procedure or postoperatively via an in-dwelling lytic catheter. The Indigo System has demonstrated high rates of revascularization with consistent success. The PRISM trial, a retrospective case analysis assessing the rate of TIMI 2-3 flow after the use of Indigo and specifically the XTRACT technique, showed an 87.2% rate of revascularization post-Indigo and subsequent treatment of underlying stenosis in the same setting.1 The newly completed study studying the same primary outcome as PRISM, the INDIAN registry, showed an even higher rate of revascularization, 88.7%.2 Sustained aspiration for ALI could potentially increase the revascularization rate by serving as an effective single-session frontline option.

1. Saxon RR, Benenati JF, Teigen C, et al. Utility of a power aspiration-based extraction technique as an initial and secondary approach in the treatment of peripheral arterial thromboembolism: results of the multicenter PRISM trial. J Vasc Interv Radiol. 2018;29:92-100. doi: 10.1016/j.jvir.2017.08.019

2. As presented on November 21, 2019, at VEITH 2019 by Dr. Gianmarco de Donato, University of Siena, Italy.


D. Chris Metzger, MD
Ballad Health System CVA Heart & Vascular Institute
Kingsport, Tennessee
Disclosures: Consultant to Penumbra, Inc.


A 68-year-old man presented with a sudden coolness in both legs after stopping apixaban therapy for 3 days. The patient’s right leg was completely cold, insensate, and immobile from the thigh down. The patient’s left leg was cool to the touch with signs of paresthesia but with motor function still intact. CT revealed bilateral ALI (Figure 1).

Figure 1. CT showing bilateral ALI.


  • A wire test was conducted in the right leg to determine the composition of the clot. There was poor distal runoff after wire crossing, indicating acute thrombus (Figure 2).
  • The Indigo System Catheter CAT8 was used in the superficial femoral artery (SFA) with several passes until flow was restored and the patient could move and feel his leg again (Figure 3).
  • The wire test was done once again in the left leg, showing poor flow, a BTK clot, and evidence of chronicity. The wire was removed, and the CAT8 was used to remove thrombus from the popliteal artery.
  • Fluoroscopy showed additional thrombus in the tibioperoneal trunk (TPT) (Figure 4). Due to its smaller profile, the CAT RX was advanced coaxially through the CAT8 to resolve further thrombus in the TPT.
  • Final fluoroscopy of the left leg showed restored distal runoff (Figure 5).

Figure 2. Poor distal runoff from acute thrombus.

Figure 3. Post-CAT8 on the right leg.

Figure 4. Poor flow through the left TPT.

Figure 5. Restored distal flow to the left TPT.


For bilateral occlusions where thrombus is laced throughout the SFA in both legs and with potential for acute-to-chronic occlusion distally, the Indigo System provides a frontline treatment option that potentially preserves limb viability. With the severity of this patient’s symptoms, immediate relief was required to maintain limb viability and the different profiles of the Indigo catheters provided a complete portfolio for aspiration in the arterial vasculature, starting with the CAT8 in the SFA and BTK to using the CAT RX coaxially in the heavily diseased TPT. The Indigo System of catheters are trackable, deliverable, and can provide a nice treatment option for complex patients.

Disclaimer: The opinions and clinical experiences presented herein are for informational purposes only. The results may not be predictive of all patients. Individual results may vary depending on patient-specific attributes.